Global Electrophysiology Devices Market Overview:
Electrophysiology involves the study of the electrical activity of the heart to diagnose and monitor any arrhythmia. Indications for electrophysiology include bradycardia, tachycardia, atrial fibrillation, ventricular tachycardia, ventricular fibrillation, and other arrhythmias. The test is performed by inserting catheters and then wire electrodes, which measure electrical activity, through blood vessels that enter the heart. According to the world health organizations, Cardiovascular diseases (CVDs) are the number 1 cause of death globally, taking an estimated 17.9 million lives each year. CVDs are a group of disorders of the heart and blood vessels and include coronary heart disease, cerebrovascular disease, rheumatic heart disease, and other conditions.
- Growing cases of arrhythmia
- Ineffective pharmacological treatments
- The rising number of geriatric population
- Increasing government body support
- Stringent healthcare regulations
- Increasing prevalence of cardiovascular disorder
- Excise tax on medical devices
The companies are exploring the market by adopting expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions across the globe to gain a competitive advantage through combined collaborations.
Some of the key players profiled in the report are Siemens Healthcare (Germany), Boston Scientific (United States), Abbott Laboratories(United States), GE Healthcare(United States), Johnson & Johnson Company(United States), St.Jude Medical Inc. (United States), Biotronik SE & Co. KG(United States), Topera, Inc(United States), Microport Scientific Corporation (China) and Molecular Devices(United States). Analyst at AMA Research see United States Players to retain maximum share of Global Electrophysiology Devices market by 2025. Considering Market by Distribution Channel, the sub-segment i.e. Online will boost the Electrophysiology Devices market. Considering Market by Indication , the sub-segment i.e. Atrial Fibrillation (AF) will boost the Electrophysiology Devices market.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be provided prior to purchase
The top-down and bottom-up approaches are used to estimate and validate the size of the Global Electrophysiology Devices market.
In order to reach an exhaustive list of functional and relevant players various industry classification standards are closely followed such as NAICS, ICB, SIC to penetrate deep in important geographies by players and a thorough validation test is conducted to reach most relevant players for survey in Electrophysiology Devices market.
In order to make priority list sorting is done based on revenue generated based on latest reporting with the help of paid databases such as Factiva, Bloomberg etc.
Finally the questionnaire is set and specifically designed to address all the necessities for primary data collection after getting prior appointment by targeting key target audience that includes New Entrants/Investors, Analysts and Strategic Business Planners, Electrophysiology Devices Manufacturer, Government Regulatory and Research Organizations and End-Use Industry.
This helps us to gather the data related to players revenue, operating cycle and expense, profit along with product or service growth etc.
Almost 70-80% of data is collected through primary medium and further validation is done through various secondary sources that includes Regulators, World Bank, Association, Company Website, SEC filings, OTC BB, USPTO, EPO, Annual reports, press releases etc.